Literature DB >> 11158230

Segment-specific c-ErbB2 expression in human autosomal recessive polycystic kidney disease.

Koichi Nakanishi1, William E Sweeney1, Ellis D Avner1.   

Abstract

c-ErbB2 (also referred to as Neu or HER2), a transmembrane glycoprotein with intrinsic tyrosine kinase activity, is structurally related to epidermal growth factor receptor (EGFR) and forms active heterodimers with EGFR as well as other members of the EGFR family. c-ErbB2 is reported to mediate differentiation and proliferation in epithelial cells and is expressed in a tissue-specific and developmental stage-specific manner. Given the role of EGFR in cystic renal epithelial hyperplasia and the immature phenotype of cystic renal epithelial cells, the segment-specific expression pattern of c-ErbB2 in human autosomal recessive polycystic kidney disease (ARPKD) was examined in nine ARPKD kidney specimens ranging from gestational age 17 wk through postnatal age 4 wk. c-ErbB2 staining of human ARPKD samples showed increased expression with increasing gestational age compared with normal human fetal and postnatal kidneys. This increased c-ErbB2 expression was primarily localized to the apical surfaces of cystic collecting tubule cells, similar to the pattern of EGFR expression, and paralleled collecting tubular cyst formation and growth.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11158230     DOI: 10.1681/ASN.V122379

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  10 in total

1.  ErbB4 modulates tubular cell polarity and lumen diameter during kidney development.

Authors:  Ville Veikkolainen; Florence Naillat; Antti Railo; Lijun Chi; Aki Manninen; Peter Hohenstein; Nick Hastie; Seppo Vainio; Klaus Elenius
Journal:  J Am Soc Nephrol       Date:  2011-11-10       Impact factor: 10.121

Review 2.  Potential pharmacological interventions in polycystic kidney disease.

Authors:  Amirali Masoumi; Berenice Reed-Gitomer; Catherine Kelleher; Robert W Schrier
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 3.  Epidermal growth factor-mediated proliferation and sodium transport in normal and PKD epithelial cells.

Authors:  Nadezhda N Zheleznova; Patricia D Wilson; Alexander Staruschenko
Journal:  Biochim Biophys Acta       Date:  2010-10-16

4.  The renin-angiotensin system and hypertension in autosomal recessive polycystic kidney disease.

Authors:  Miwa Goto; Nita Hoxha; Rania Osman; Katherine Macrae Dell
Journal:  Pediatr Nephrol       Date:  2010-08-27       Impact factor: 3.714

Review 5.  Renal toxicity of targeted therapies.

Authors:  Ronan J Kelly; Bertrand Billemont; Olivier Rixe
Journal:  Target Oncol       Date:  2009-05-06       Impact factor: 4.493

6.  State of the human proteome in 2013 as viewed through PeptideAtlas: comparing the kidney, urine, and plasma proteomes for the biology- and disease-driven Human Proteome Project.

Authors:  Terry Farrah; Eric W Deutsch; Gilbert S Omenn; Zhi Sun; Julian D Watts; Tadashi Yamamoto; David Shteynberg; Micheleen M Harris; Robert L Moritz
Journal:  J Proteome Res       Date:  2013-12-06       Impact factor: 4.466

Review 7.  Proliferative signaling by ERBB proteins and RAF/MEK/ERK effectors in polycystic kidney disease.

Authors:  Mitchell I Parker; Anna S Nikonova; Danlin Sun; Erica A Golemis
Journal:  Cell Signal       Date:  2019-12-09       Impact factor: 4.315

8.  Effect of acute acid-base disturbances on ErbB1/2 tyrosine phosphorylation in rabbit renal proximal tubules.

Authors:  Lara A Skelton; Walter F Boron
Journal:  Am J Physiol Renal Physiol       Date:  2013-10-16

9.  The lonidamine derivative H2-gamendazole reduces cyst formation in polycystic kidney disease.

Authors:  Shirin V Sundar; Julie Xia Zhou; Brenda S Magenheimer; Gail A Reif; Darren P Wallace; Gunda I Georg; Sudhakar R Jakkaraj; Joseph S Tash; Alan S L Yu; Xiaogang Li; James P Calvet
Journal:  Am J Physiol Renal Physiol       Date:  2022-08-18

Review 10.  Advances in Autosomal Dominant Polycystic Kidney Disease: A Clinical Review.

Authors:  Niloofar Nobakht; Ramy M Hanna; Maha Al-Baghdadi; Khalid Mohammed Ameen; Farid Arman; Ehsan Nobahkt; Mohammad Kamgar; Anjay Rastogi
Journal:  Kidney Med       Date:  2020-02-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.